Skip to the page

Data / Form D filings / NV Therapeutics, Inc.

NV Therapeutics, Inc.: Form D filing

NV Therapeutics, Inc., a company in Berkeley, CA, filed a Form D with the SEC in 2025. The latest, on March 14, 2025, reports $3 million sold of a $7.5 million offering to 1 investor.

SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.

Company details from the filing

Address
2625 DURANT AVENUE, Berkeley, CA, 94720
Phone
(617) 778-2500
Industry
Other
Entity type
Corporation
Incorporated in
Delaware
Year incorporated
2024
Revenue range
Decline to Disclose
Exemptions claimed
Rule 506(b)
SEC identifier (CIK)
2060599

Form D filings

FiledTypeOfferingSoldRemainingInvestorsFirst saleFiling
Mar 14, 2025New notice$7,500,000$3,000,000$4,500,0001Sep 13, 2024sec.gov

Executive officers and directors named in the filing

NameRoleNote in the filing
Audrey KozlovDirector
Daniel DeverDirector
Kevin HoldenExecutive Officer, Director, Promoter
Dmitry KuzminDirector

Other companies in California that filed recently

Every Form D from the week of Mar 10, 2025 · All recent filings in California · All recent Other filings

Read from SEC EDGAR. Amount sold is what NV Therapeutics, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.